A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model

被引:0
|
作者
Lorenzo Argante
Victoria Abbing-Karahagopian
Kumaran Vadivelu
Rino Rappuoli
Duccio Medini
机构
[1] GSK,
[2] GSK,undefined
来源
关键词
Invasive meningococcal disease; IMD; MenB; 4CMenB; Bexsero; Effectiveness; VE; Incidence model; Screening method; Epidemiology;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] 4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents
    Alessia Biolchi
    Sara Tomei
    Brunella Brunelli
    Maria Giuliani
    Stefania Bambini
    Ray Borrow
    Heike Claus
    Maria Cecilia O. Gorla
    Eva Hong
    Ana Paula S. Lemos
    Jay Lucidarme
    Muhamed-Kheir Taha
    Ulrich Vogel
    Sonia Budroni
    Marzia M. Giuliani
    Rino Rappuoli
    Philip Boucher
    Mariagrazia Pizza
    Infectious Diseases and Therapy, 2021, 10 : 307 - 316
  • [42] First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England
    Ladhani, Shamez N.
    Campbell, Helen
    Andrews, Nick
    Parikh, Sydel R.
    White, Joanne
    Edelstein, Michael
    Clark, Stephen A.
    Lucidarme, Jay
    Borrow, Ray
    Ramsay, Mary E.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E1661 - E1668
  • [43] Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
    Biolchi, Alessia
    Tomei, Sara
    Santini, Laura
    Welsch, Jo Anne
    Toneatto, Daniela
    Gaitatzis, Nikolaos
    Bai, Xilian
    Borrow, Ray
    Giuliani, Marzia Monica
    Mori, Elena
    Pizza, Mariagrazia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) : 725 - 731
  • [44] Outcomes of meningococcal serogroup B disease in children after implementation of routine infant 4CMenB vaccination in England: an active, prospective, national surveillance study
    Mensah, Anna A.
    Campbell, Helen
    Clark, Stephen A.
    Ribeiro, Sonia
    Lucidarme, Jay
    Bai, Xilian
    Borrow, Ray
    Ladhani, Shamez N.
    LANCET CHILD & ADOLESCENT HEALTH, 2023, 7 (03): : 190 - 198
  • [45] Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
    Efron, Adriana
    Biolchi, Alessia
    Pereira, Cecilia Sorhouet
    Tomei, Sara
    Campos, Josefina
    De Belder, Denise
    Moscoloni, Maria Alicia
    Santos, Mauricio
    Vidal, Gabriela
    Nocita, Florencia
    Vizzotti, Carla
    Pizza, Mariagrazia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [46] A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)
    Marshall, Gary S.
    Abbing-Karahagopian, Victoria
    Marshall, Helen S.
    Cenci, Silvia
    Conway, James H.
    Occhipinti, Emilia
    Bekkat-Berkani, Rafik
    Banzhoff, Angelika
    Sohn, Woo-Yun
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 530 - 544
  • [47] Invasive serogroup B meningococci in England following three years of 4CMenB vaccination - First real-world data
    Lucidarme, Jay
    Bai, Xilian
    Lekshmi, Aiswarya
    Clark, Stephen A.
    Willerton, Laura
    Ribeiro, Sonia
    Campbell, Helen
    Serino, Laura
    De Paola, Rosita
    Holland, Ann
    Louth, Jennifer
    Ramsay, Mary E.
    Ladhani, Shamez N.
    Borrow, Ray
    JOURNAL OF INFECTION, 2022, 84 (02) : 136 - 144
  • [48] Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease (vol 11, pg 367, 2022)
    Scholz, Stefan
    Schwarz, Magdalena
    Beck, Ekkehard
    Meszaros, Kinga
    Schneider, Melanie
    Ultsch, Bernhard
    Greiner, Wolfgang
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (03) : 1311 - 1311
  • [49] Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
    Sereikaite, Emilija
    Plepyte, Ruta
    Petrutiene, Aurelija
    Stravinskiene, Dovile
    Kucinskaite-Kodze, Indre
    Gegzna, Vilmantas
    Ivaskeviciene, Inga
    Zvirbliene, Aurelija
    Pleckaityte, Milda
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [50] Impact of a Meningococcal Protein-based Serogroup B Vaccine on Serogroup W Invasive Disease in Children
    Marshall, Helen S.
    Maiden, Martin C. J.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E1669 - E1671